MELISSA LOGSDON: Open Payments
NPI 1902247992 · MUNFORDVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$147 in 9 payments from 7 companies in 2025. Trend: 2023 $29 · 2024 $0 · 2025 $147
Food & beverage: $147
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $29 |
| ABBVIE INC. | 1 | $20 |
| Amgen Inc. | 1 | $18 |
| Corcept Therapeutics | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Wegovy, Kerendia, UBRELVY, OTEZLA, Korlym, TRELEGY ELLIPTA, BREZTRI.
Industry payments across KY — which companies pay providers there.
